Wall Street rises as Syria fears ease; healthcare stocks jump

Merck rose 2.5 percent after the company presented positive data on its cancer drug Keytruda, driving a 0.7 percent gain in the healthcare index. "The action was well-received ... and that's giving a chance for investors to focus on macro news and earnings," said Peter Cardillo, chief market economist at Spartan Capital Securities in New York. Attention turned to what is expected to be a robust first-quarter earnings season.

https://finance.yahoo.com/news/wall-...html?.tsrc=rss